Signaling pathways in skin cancers and the protective functions of melatonin
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Melatonin, a hormone regulating sleep and immunity, shows promise in preventing and treating skin cancers through antioxidant and photoprotective effects. Further research is needed to optimize its use in cancer therapy.
Area Of Science
- Oncology
- Endocrinology
- Dermatology
Background
- Melatonin, a pineal gland hormone, regulates sleep-wake cycles, immune function, and antioxidant responses.
- Emerging evidence highlights melatonin's protective role against melanoma and non-melanoma skin cancers.
Purpose Of The Study
- To provide a comprehensive overview of melatonin's mechanisms in skin cancer prevention and treatment.
- To focus on melatonin's antioxidant, photoprotective, and radioprotective properties in skin cancer.
Main Methods
- Review of existing scientific literature on melatonin and skin cancer.
- Analysis of melatonin's modulation of key signaling pathways in skin cancer.
- Exploration of synergistic effects with conventional oncology treatments.
Main Results
- Melatonin exhibits significant antioxidant, photoprotective, and radioprotective effects against skin cancers.
- Melatonin modulates critical signaling pathways involved in skin cancer development.
- Synergistic effects observed between melatonin and radiotherapy, chemotherapy, and targeted therapies.
Conclusions
- Melatonin demonstrates multifaceted anticancer mechanisms relevant to skin cancer.
- Melatonin holds potential as an adjunct therapy to improve cancer treatment outcomes and reduce side effects.
- Further research is required to optimize clinical applications and understand the safety profile of melatonin in oncology.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...